Skip to main content

CORRECTION article

Front. Pediatr., 30 June 2022
Sec. Genetics of Common and Rare Diseases
Volume 10 - 2022 | https://doi.org/10.3389/fped.2022.961964

Corrigendum: Pathogenicity and Long-Term Outcomes of Liddle Syndrome Caused by a Nonsense Mutation of SCNN1G in a Chinese Family

This article is a correction to:

  1. Pathogenicity and Long-Term Outcomes of Liddle Syndrome Caused by a Nonsense Mutation of SCNN1G in a Chinese Family

    1. Read original article
\nDi ZhangDi Zhang1Yi QuYi Qu1Xue-Qi DongXue-Qi Dong1Yi-Ting LuYi-Ting Lu1Kun-Qi YangKun-Qi Yang1Xin-Chang LiuXin-Chang Liu1Peng FanPeng Fan1Yu-Xiao HuYu-Xiao Hu2Chun-Xue YangChun-Xue Yang2Ling-Gen GaoLing-Gen Gao3Ya-Xin Liu Ya-Xin Liu2*Xian-Liang Zhou Xian-Liang Zhou1*
  • 1Department of Cardiology, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Fuwai Hospital, Beijing, China
  • 2Emergency and Critical Care Center, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Fuwai Hospital, Beijing, China
  • 3Department of Geriatric Cardiology, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China

A Corrigendum on
Pathogenicity and Long-Term Outcomes of Liddle Syndrome Caused by a Nonsense Mutation of SCNN1G in a Chinese Family

by Zhang, D., Qu, Y., Dong, X-Q., Lu, Y-T., Yang, K-Q., Liu, X-C., Fan, P., Hu, Y-X., Yang, C-X., Gao, L-G., Liu, Y-X., and Zhou, X-L. (2022). Front. Pediatr. 10:887214. doi: 10.3389/fped.2022.887214

In the published article, corresponding author “Xian-Liang Zhou” was assigned the affiliation of “Department of Geriatric Cardiology, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.” The affiliation of author “Xian-Liang Zhou” should be “Department of Cardiology, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Fuwai Hospital, Beijing, China.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: Liddle syndrome, pathogenicity, pediatrics, amiloride-sensitive current, longterm prognosis

Citation: Zhang D, Qu Y, Dong X-Q, Lu Y-T, Yang K-Q, Liu X-C, Fan P, Hu Y-X, Yang C-X, Gao L-G, Liu Y-X and Zhou X-L (2022) Corrigendum: Pathogenicity and Long-Term Outcomes of Liddle Syndrome Caused by a Nonsense Mutation of SCNN1G in a Chinese Family. Front. Pediatr. 10:961964. doi: 10.3389/fped.2022.961964

Received: 05 June 2022; Accepted: 06 June 2022;
Published: 30 June 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Zhang, Qu, Dong, Lu, Yang, Liu, Fan, Hu, Yang, Gao, Liu and Zhou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ya-Xin Liu, yaxinliu1978@hotmail.com; Xian-Liang Zhou, zhouxianliang0326@hotmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.